#News for #investors and #media: ADVANZ PHARMA has expanded its specialty brands portfolio by acquiring certain APAC (excluding Japan and China) rights to a specialty medicine from Bayer. This strategic move underscores our commitment to leveraging our commercial footprint and global partner network to bring innovative treatments to patients worldwide. More details here: https://bit.ly/3B56fOO #partnerofchoice #growth #specialtypharma
ADVANZ PHARMA’s Post
More Relevant Posts
-
Pharmaceutical Executive | Senior Business Development Manager | Driving Innovation and Excellence in CDMO Solutions
Don't miss this very interesting Webinar regarding Upcoming Trends in Pharma Contract Manufacturing featuring top-notch industry experts!
📅Webinar Reminder!📅 Our free webinar: Upcoming Trends In Pharma Contract Manufacturing is taking place this Thursday the 30th of January,15:00pm CET. Don't miss this opportunity to stay at the forefront of industry innovation! Sign up here: https://lnkd.in/eVnGCgNF The webinar will feature five distinguished industry experts and they will explore emerging trends, challenges, and predictions for 2025, covering topics such as advancements in manufacturing technologies, regulatory shifts, supply chain strategies, and sustainability initiatives. Our speakers include: Gil Roth, President at - PBOA - Pharma & Biopharma Outsourcing Association Maik Talarczyk, Head, PMO ESO at Sandoz Kyriakos Kansos, Partner at Fuliginous Management Consulting George Ntortas, Partner at Fuliginous Management Consulting Philip Coetzee, Director CMO Management at Daiichi Sankyo Europe GmbH Sign up today & receive a discount on our physical Pharma Contract Manufacturing 2025 event taking place in Berlin this March! https://lnkd.in/eVnGCgNF #pharma #webinar #industryexperts
-
-
The speed of innovative product launches by global pharma companies in China is increasing rapidly! The time taken to launch products have decreased significantly, opening new opportunities. Get the full insights here https://bit.ly/40R6jM7 #ForecastLink #ChinaPharmaMarket #PharmaOpportunities
-
-
Our Chairman, Mr. Sushil Suri, shares his visionary insights in The Economic Times article, "India’s Growing Prowess as a Global Leader in Healthcare Innovation." 🩺🌍 As a key contributor, Mr. Suri highlights how Indian pharmaceutical companies are setting new benchmarks in quality, innovation, and accessibility, strengthening India’s position on the global healthcare stage. Read the full article to explore how India is shaping the future of healthcare: https://lnkd.in/gRUGX2sQ #HealthcareInnovation #IndiaPharma #Leadership #Morepen
-
-
Japan is a global leader in pharmaceuticals and offers unmatched opportunities for innovative businesses. With its aging population, advanced healthcare system, and favorable regulatory environment, Japan is a gateway to global success. Here are the Top 5 Reasons why Japan should be your next pharma destination. Watch the video now! Freyr’s regulatory experts are here to guide you through every step—from submission to market entry. Let’s make your Japan expansion seamless! https://lnkd.in/gjtPYEAB #RegulatoryAffairs #japan #HealthcareInnovation #DrugDevelopment #PharmaReg
-
🧬 Pharma Now is giving you an exclusive chance to have your questions answered directly by the speakers at the #GlobalPharmaSupplyChain, organized by BrainLinx! 🎤 Meet our expert speakers: 👨💼 Faris Hattar, Associate Director, Hikma Pharmaceuticals 👨💼 Pablo Tovar Montaño, Economic & Social Affairs Team, EFPIA - European Federation of Pharmaceutical Industries and Associations 👨💼 Nico Höler, CEO & Co-Founder, Tec4med These industry leaders are ready to share their insights on the most pressing challenges and innovations in pharma supply. Now’s your opportunity to ask them directly! Drop your questions in the comments below, and get the expert insights. Don’t miss out on this exclusive chance to learn from the best in the business! 💬 #PharmaNow #AskTheExperts #GlobalPharmaSupplyChain #PharmaIndustry #SupplyChainExcellence #PharmaTrends #IndustryInsights
-
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Chinese drugmakers still lag in R&D depth despite outpacing Europeans in new launches >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #healthcare #productmarketing #pharmaceutical #pharma
-
Thoughts on this? >> Chinese drugmakers still lag in R&D depth despite outpacing Europeans in new launches >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #productmarketing #pharma #pharmaceutical
-
https://lnkd.in/dm9CfxPu EXECUTVE INTERVIEW - Aptar: Advancing Patient-Centric Drug Delivery & Digital Health Solutions: Gael Touya, President of Aptar Pharma, and Sai Shankar, President, M&A, Strategy, BD, Marketing, Drug Services, Aptar Pharma, discuss the burgeoning potential in the future of pharma and digital health, how the company is a strategic partner to key players in these spaces, and the investments Aptar is making to support the growing demand.
-
-
Unlock strategic insights for launching new pharma divisions in India! Discover how top companies navigate market dynamics. Explore more on: https://lnkd.in/dRJRGmtX #PharmaStrategy #MarketInsights #PharmaIndustry
-
-
🚀 𝗕𝗼𝗼𝘀𝘁 𝗬𝗼𝘂𝗿 𝗣𝗵𝗮𝗿𝗺𝗮 𝗣𝗿𝗶𝗰𝗶𝗻𝗴 𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲! Excited to announce Module 4: Innovative Pharma Pricing Models in the 𝗘𝗣𝗣 𝗖𝗲𝗿𝘁𝗶𝗳𝗶𝗲𝗱 𝗣𝗿𝗶𝗰𝗶𝗻𝗴 𝗠𝗮𝗻𝗮𝗴𝗲𝗿 (𝗖𝗣𝗠) 𝗣𝗵𝗮𝗿𝗺𝗮 program. In this module, we dive into: • New trends in pharma pricing • Outcome-based pricing models • Managed entry agreements • How to price CAR-T therapies If you're looking to stay ahead in pharma pricing, this is the place to be! Join global peers and our Experts Paolo Correale, Tancredi Sebastiano Fichera in exploring cutting-edge strategies to drive real impact in your organization. Know more - https://lnkd.in/eVUqUnE6 #PharmaPricing #CPMPharma #CAR-T #PricingInnovation #ManagedEntry #OutcomeBasedPricing
-
Commercial Director | BSc in Physiology, Market Access Expert
3moCongrats!